Evaluation of the effect of a barley-based formulation on acne

Evaluation of the effect of a barley-based formulation on acne vulgaris:A randomized controlled trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20221208056755N1

Enrollment

136

Registered

2025-11-19

Start date

2023-03-21

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne vulgaris. Acne vulgaris

Interventions

Intervention 1: The intervention group will receive 15 gram sachets containing barley extract powder, prepared and packaged by Niak Pharmaceutical Company, twice a day for 4 weeks. The participants sh

Eligibility

Sex/Gender

All

Age

12 Years to No maximum

Inclusion criteria

Inclusion criteria: All people over 12 years old with moderate to severe acne vulgaris lesions

Exclusion criteria

Exclusion criteria: Pregnancy, allergy to barley, autoimmune diseases and immunodeficiency and lack of consent to participate in the study

Design outcomes

Primary

Measure	Time frame
Number of Acne. Timepoint: Evaluation the number of Acne in 28 days. Method of measurement: Observational.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohamadreza Rezaeizadeh

Fasa University of Medical Sciences

dr.rezai.z@gmail.com+98 71 5335 0994

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026